Q07869 (PPARA_HUMAN) Homo sapiens (Human)

Peroxisome proliferator-activated receptor alpha UniProtKBInterProSTRINGInteractive Modelling

468 aa; Sequence (Fasta) ; (Isoform 2); 2 identical sequences: Homo sapiens: F1D8S4; Gorilla gorilla gorilla: A0A2I2Z0P2

Available Structures

60 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
Structural basis for iloprost as a dual PPARalpha/delta agonist Heteromer
Q86YN6;
IL2;196-468
Assess
Structure of PPARalpha with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid Heteromer
Q15788;
ET1;199-468
Assess
X-ray structure of human PPARalpha ligand binding domain-fenofibric acid-SRC1 coactivator peptide c… Heteromer
Q15788;
F5A;200-468
Assess
X-ray structure of human PPARalpha ligand binding domain-clofibric acid-SRC1 coactivator peptide co… Heteromer
Q15788;
E0O;200-468
Assess
the crystal structure of the human PPARaplpha ligand binding domain in complex with a a-hydroxyimin… Heteromer
Q15788;
MMB;199-467
Assess
X-ray structure of human PPARalpha ligand binding domain-bezafibrate-SRC1 coactivator peptide co-cr… Heteromer
Q15788;
PEM;200-468
Assess
Novel natural PPARalpha agonist with a unique binding mode Heteromer
Q15788;
SAU;200-468
Assess
Crystal structure of the human PPAR-alpha ligand-binding domain in complex with an antagonist GW647… Heteromer
Q9Y618;
471;200-468
Assess
X-ray structure of human PPARalpha ligand binding domain-pemafibrate-SRC1 coactivator peptide co-cr… Heteromer
Q15788;
P7F;GOL;201-468
Assess
X-ray structure of human PPARalpha ligand binding domain-eicosapentaenoic acid (EPA)-SRC1 coactivat… Heteromer
Q15788;
EPA;GOL;201-468
Assess
X-ray structure of human PPARalpha ligand binding domain-intrinsic fatty acid (E. coli origin)-SRC1… Heteromer
Q15788;
PLM;GOL;202-468
Assess
a crystal structure of PPAR alpha bound with SRC1 peptide and GW735 Heteromer
Q15788;
735;202-468
Assess
X-ray structure of human PPARalpha ligand binding domain-GW7647-SRC1 coactivator peptide co-crystal… Heteromer
Q15788;
2VN;202-468
Assess
Aleglitazar, a new, potent, and balanced PPAR alpha/gamma agonist for the treatment of type II diab… Heteromer
Q15788;
RO7;202-468
Assess
Design and biological evaluation of novel, balanced dual PPARa/g agonists Heteromer
Q15788;
CTM;202-468
Assess
The 2.5 Angstrom resolution crystal structure of the human PPARalpha ligand binding domain bound wi… Heteromer
Q15788;
544;202-468
Assess
Structure of PPARalpha-LBD/pemafibrate/SRC1 peptide Heteromer
Q15788;
P7F;202-467
Assess
Ternary complex of hPPARalpha ligand binding domain, 17-oxoDHA and a SRC1 peptide Heteromer
Q15788;
4M5;204-468
Assess
Human PPAR alpha ligand binding domain in complex with a synthetic agonist (compound A) Heteromer
Q9UBK2;
T02;205-467
Assess
Human PPAR alpha ligand binding domain in complex with a synthetic agonist (compound B) Heteromer
Q9UBK2;
T06;205-467
Assess
Crystal structure of peroxisome proliferator-activatedeceptor alpha (PPARalpha) complex with N-3-((…homo-2-merNKS;196-468
Assess
Crystal structure of peroxisome proliferator-activatedeceptor alpha (PPARalpha) complex with N-3-((…homo-2-mer7HA;196-468
Assess
HUMAN PPAR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH APHM6 OBTAINED BY SOAKINGhomo-2-merHW3;200-468
Assess
HUMAN PPAR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH APHM6 OBTAINED BY COCRYSTALLIZATIONhomo-2-merHW3;200-468
Assess
HUMAN PPAR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH YN4pai OBTAINED BY SOAKINGhomo-2-merHVX;200-468
Assess
HUMAN PPAR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH TIPP703 OBTAINED BY SOAKINGhomo-2-merS44;200-468
Assess
CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN FROM HUMAN PPAR-ALPHA IN COMPLEX WITH THE AGONIST AZ…monomerNA;AZ2;CPQ;199-468
Assess
X-ray structure of human PPARalpha ligand binding domain-eicosapentaenoic acid (EPA) co-crystals ob…monomerGOL;EPA;200-468
Assess
X-ray structure of human PPARalpha ligand binding domain-intrinsic fatty acid (E. coli origin) co-c…monomerGOL;PLM;200-468
Assess
X-ray structure of human PPARalpha ligand binding domain-tetradecylthioacetic acid (TTA) co-crystal…monomerGOL;T4T;200-468
Assess
X-ray structure of human PPARalpha ligand binding domain-arachidonic acid co-crystals obtained by d…monomerGOL;ACD;200-468
Assess
X-ray structure of human PPARalpha ligand binding domain-stearic acid co-crystals obtained by delip…monomerGOL;STE;200-468
Assess
X-ray structure of human PPARalpha ligand binding domain-pemafibrate co-crystals obtained by delipi…monomerGOL;P7F;200-468
Assess
X-ray structure of human PPARalpha ligand binding domain-tetradecylthioacetic acid (TTA) co-crystal…monomerGOL;T4T;200-468
Assess
X-ray structure of human PPARalpha ligand binding domain-GW7647 co-crystals obtained by delipidatio…monomerGOL;2VN;200-468
Assess
X-ray structure of human PPARalpha ligand binding domain-GW7647 co-crystals obtained by cross-seedi…monomerGOL;2VN;200-468
Assess
X-ray structure of human PPARalpha ligand binding domain-pemafibrate co-crystals obtained by cross-…monomerGOL;P7F;200-468
Assess
X-ray structure of human PPARalpha ligand binding domain-GW7647 co-crystals obtained by soakingmonomer2VN;GOL;200-468
Assess
X-ray structure of human PPARalpha ligand binding domain-ciprofibrate co-crystals obtained by delip…monomerGOL;C5F;200-468
Assess
X-ray structure of human PPARalpha ligand binding domain-saroglitazar co-crystals obtained by delip…monomerEWR;200-468
Assess
X-ray structure of human PPARalpha ligand binding domain-fenofibric acid co-crystals obtained by de…monomerF5A;200-468
Assess
Crystal Structure of PPARalpha ligand binding domain with BMS-631707monomerCPQ;REW;199-467
Assess
X-ray structure of human PPARalpha ligand binding domain-saroglitazar co-crystals obtained by soaki…monomerEWR;200-468
Assess
X-ray structure of human PPARalpha ligand binding domain-GW9662-gemfibrozil co-crystals obtained by…monomerGW9;200-468
Assess
X-ray structure of human PPARalpha ligand binding domain-GW9662-clofibric acid co-crystals obtained…monomerGW9;200-468
Assess
X-ray structure of human PPARalpha ligand binding domain-GW9662-ciprofibrate co-crystals obtained b…monomerGW9;C5F;200-468
Assess
X-ray structure of human PPARalpha ligand binding domain-GW9662-fenofibric acid co-crystals obtaine…monomerGW9;F5A;200-468
Assess
X-ray structure of human PPARalpha ligand binding domain-5,8,11,14-eicosatetraynoic Acid (ETYA) co-…monomerGOL;ITY;201-468
Assess
X-ray structure of human PPARalpha ligand binding domain-palmitic acid co-crystals obtained by deli…monomerGOL;PLM;202-468
Assess
X-ray structure of human PPARalpha ligand binding domain-5,8,11,14-eicosatetraynoic acid (ETYA) co-…monomerGOL;ITY;202-468
Assess
X-ray structure of human PPARalpha ligand binding domain-pemafibrate co-crystals obtained by soakingmonomerGOL;P7F;202-468
Assess
X-ray structure of human PPARalpha ligand binding domain-oleic acid co-crystals obtained by delipid…monomerGOL;OLA;202-468
Assess
Human PPAR alpha ligand binding domain in complex with a synthetic agonist APHM13monomer13M;202-468
Assess
X-ray structure of human PPARalpha ligand binding domain-Wy14643 co-crystals obtained by co-crystal…monomerWY1;202-468
Assess
Crystal structure of the complex PPARalpha/AL26-29monomer65W;202-468
Assess
X-ray structure of human PPARalpha ligand binding domain-Wy14643 co-crystals obtained by soakingmonomerWY1;202-468
Assess
Human PPAR alpha ligand binding domain in complex with a synthetic agonist TIPP703monomerS44;202-468
Assess
X-ray structure of human PPARalpha ligand binding domain-Wy14643 co-crystals obtained by delipidati…monomerWY1;202-468
Assess
Structural basis for GL479 a dual Peroxisome Proliferator-Activated Receptor alpha agonistmonomerY1N;204-467
Assess
Structure of PPARalpha in complex with WY14643monomerEDO;WY1;204-466
Assess

6 Homology models

Oligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
monomerZN;0.713dzy.1.B99-468
64.96
Assess
monomerZN;0.534iqr.2.A100-466
28.21
Assess
monomerZN;0.524iqr.2.B100-466
28.21
Assess
monomerZN;0.523dzu.1.A102-460
34.81
Assess
monomerZN;0.514nqa.2.A102-461
34.94
Assess
monomerZN;0.504nqa.1.A102-461
34.94
Assess

1 Homology model built on isoform sequence

IsoformOligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
Isoform 2monomerZN;0.663dzu.1.B99-173
77.92
Assess

Alignments